Skip to main content

Table 1 Demographic characteristics and comorbidities of the cervical cancer and control groups

From: The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study

Variable Cervical cancer group (N = 1,013) No.(%) Control group (N = 2,026) No.(%) p
Age, year    <0.001
44 366 (36.1) 641 (31.6)  
45–54 325 (32.1) 556 (27.4)  
55–64 155 (15.3) 351 (17.3)  
65–74 130 (12.8) 325 (16.0)  
75 37 (3.7) 153 (7.6)  
Hypertension    <0.001
Yes 256 (25.3) 395 (19.5)  
No 757 (74.7) 1631 (80.5)  
Diabetes    0.22
Yes 130 (12.8) 229 (11.3)  
No 883 (87.2) 1797 (88.7)  
Coronary heart disease    <0.001
Yes 92 (9.1) 90 (4.4)  
No 921 (90.9) 1936 (95.6)  
Hyperlipidemia    <0.001
Yes 36 (3.6) 30 (1.5)  
No 977 (96.4) 1996 (98.5)  
Geographic region    0.008
Northern 444 (43.8) 942 (46.5)  
Central 289 (28.5) 496 (24.5)  
Southern 262 (25.9) 518 (25.6)  
Eastern 18 (1.8) 70 (3.5)  
Urbanization level    0.06
Urban 268 (26.5) 618 (30.5)  
Suburban 464 (45.8) 870 (42.9)  
Rural 281 (27.7) 538 (26.6)  
EC    0.01
EC 1, 2 384 (37.0) 836 (41.3)  
EC 3 442 (43.6) 897 (44.3)  
EC 4 187 (18.5) 293 (14.5)